NAMPT and Alzheimer disease: Rate-limiting enzyme in the NAD+ pathway. Regulates NAD+ synthesis, thereby contributing to energy metabolism. Reduced NAD+ levels in the brain are prevalent with increasing age, and contribute to AD pathophysiology. NAD+ levels and NAMPT expression are low in the hippocampus and cortex in mice with early stage AD than in wild-type animals.